UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000001584
Receipt number R000001903
Scientific Title A Phase II study of neoadjuvant chemotherapy with S-1 and cisplatin for Stage III gastric cancer
Date of disclosure of the study information 2008/12/17
Last modified on 2015/06/17 11:14:50

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A Phase II study of neoadjuvant chemotherapy with S-1 and cisplatin for Stage III gastric cancer

Acronym

A Phase II study of neoadjuvant chemotherapy with S-1 and cisplatin for Stage III gastric cancer (KUGC03)

Scientific Title

A Phase II study of neoadjuvant chemotherapy with S-1 and cisplatin for Stage III gastric cancer

Scientific Title:Acronym

A Phase II study of neoadjuvant chemotherapy with S-1 and cisplatin for Stage III gastric cancer (KUGC03)

Region

Japan


Condition

Condition

Stage III gastric cancer

Classification by specialty

Gastrointestinal surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To evaluate safety and efficacy of neoadjuvant chemotherapy with S-1+CDDP for resectable stage III gastric cancer

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase

Phase II


Assessment

Primary outcomes

3 year progression free survival rate

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Historical

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine Maneuver

Interventions/Control_1

chemotherapy+surgery

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

80 years-old >=

Gender

Male and Female

Key inclusion criteria

1)Pathologically confirmed gastric cancer
2)cT3/4 or cN2, not Stage IV
3)No previous treatment
4)Age between 20 and 80 years old
5)ECOG 0 or 1
6)Capable of oral administration
7)Informed concent
8)Biology and biochemistry within normal limits

Key exclusion criteria

1)Active bleeding from the tumor
2)Paralysis of intestine or ileus
3)Diarrhea(watery stool)
4)Patient who requires continuous use of flucytosine, phenytoin or warfarin potassium
5)Synchronous multicancer
6)Serous infection
7)Interstitial pneumonitis or fibroid lung
8)Pleural effusion or ascites requiring control
9)Uncontrollable diabetes mellitus, uncontrollable hypertention, heart insufficiency, myocardial infarction within 6 months,uncontrolled arrhythmia or angina
10)Patient who is pregnant or in lactation, or wish to become pregnant during this study.Male patient who intends to make someone pregnant during this study
11)Patient who has experienced serious drug allergy in the past
12)Patient with severe phyciatric disease
13)Patient who is judged to be inappropriate as subject to this study by the principal investigator or the doctors in charge

Target sample size

49


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Yoshiharu SAKAI

Organization

Graduate School of Medicine, Kyoto University

Division name

Department of Surgery

Zip code


Address

54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto, JAPAN

TEL


Email



Public contact

Name of contact person

1st name
Middle name
Last name

Organization

Graduate School of Medicine, Kyoto University

Division name

Department of Surgery

Zip code


Address


TEL

075-751-3227

Homepage URL


Email

hokabe@kuhp.kyoto-u.ac.jp


Sponsor or person

Institute

Department of Surgery
Graduate School of Medicine, Kyoto University

Institute

Department

Personal name



Funding Source

Organization

Department of Surgery
Graduate School of Medicine, Kyoto University

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2008 Year 12 Month 17 Day


Related information

URL releasing protocol


Publication of results

Published


Result

URL related to results and publications

http://meetinglibrary.asco.org/content/125681-144

Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Main results already published

Date of protocol fixation

2008 Year 11 Month 07 Day

Date of IRB


Anticipated trial start date

2008 Year 12 Month 01 Day

Last follow-up date

2012 Year 12 Month 01 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2008 Year 12 Month 17 Day

Last modified on

2015 Year 06 Month 17 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000001903


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name